EFFECTS OF SMALL-SIDED GAME MANIPULATIONS ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL RESPONSES, PHYSICAL PERFORMANCE, AND TECHNICAL SKILLS IN FEMALE FOOTBALL PLAYERS

September 24, 2026 updated by: Bilal GÖK, Istanbul Gelisim University

THE EFFECT OF MANIPULATIONS APPLIED IN SMALL-SIDED GAMES ON NEUROMUSCULAR FATIGUE, PHYSIOLOGICAL, PHYSICAL AND TECHNICAL PARAMETERS IN FEMALE FOOTBALLERS

Small-sided games will represent a prevalent component of branch-specific training methodologies in football. The objective of this study will be to examine the impact of small-sided games with sprint manipulation played in a 3v3 configuration on neuromuscular fatigue, along with physical, physiological, and technical parameters, in female football players.

The study will be conducted on a group of 12 female football players (experimental: 6, control: 6) who will have been actively playing licensed football for a minimum of three years. The participants will be asked to record their performance data over a six-week period, during which their physiological and physical parameters will be measured using Catapult (GPS) systems. The degree of neuromuscular fatigue will be determined through the active vertical jump test.

The data obtained from the study will be analysed using a Repeated Measures ANOVA test, with the significance level set at p < 0.05. Data analysis will be performed using the JASP 0.19.2 software package. It is expected that the results will reveal statistically significant differences in physiological parameters such as player load and perceived exertion level. In physical parameters, statistically significant differences are anticipated in total distance, positive acceleration, vertical jump performance, and running speed zones 1-2-3-4 (p < 0.05).

Consequently, the present study will aim to demonstrate that coaches may utilise this information in the organisation of training programmes to enhance performance parameters such as total distance covered, positive acceleration, and velocity, while simultaneously reducing neuromuscular fatigue in female football players.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 23 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Participants must be between the ages of 18 and 25. Participants must have played football at least three times. Participants must not have any health issues. Participants must voluntarily take part in the study.

Exclusion Criteria:

Participants not being between the ages of 18 and 25. Participants not having played licensed football for at least three years. Participants having a health issue.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1 (Experimental)

Sprint

In the study, the experimental group was exposed to sprint manipulation, unlike the control group.

Other: Arm 2 (Control)

In the study, unlike the experimental group, the control group was given a 10-second recovery period.

In the study, unlike the experimental group, the control group was given a 10-second recovery period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Neuromuscular Fatigue (Active Vertical Jump Height)
Time Frame: Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)

Neuromuscular fatigue was assessed using the Active Vertical Jump Test (AVJT). Jump height was recorded in centimeters (cm) using a ForceDecks force platform. Each participant performed three trials with a two-minute rest between attempts, following a standardized warm-up protocol.

Baseline (pre-test), Week 3 (mid-test), and Week 6 (post-test)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Perceived Exertion Level
Time Frame: Baseline, Week 3, and Week 6

Perceived exertion was assessed using the Borg CR-10 Perceived Exertion Scale, scored from 1 (lowest) to 10 (highest), recorded 30 minutes after each training session.

Baseline, Week 3, and Week 6
Change in Maximum Heart Rate
Time Frame: Baseline, Week 3, and Week 6

Maximum heart rate was recorded using the Polar Team Pro GPS system, expressed in beats per minute (bpm).

Baseline, Week 3, and Week 6
Change in Estimated Maximal Oxygen Uptake (VO2max)
Time Frame: Baseline, Week 3, and Week 6

Aerobic capacity was estimated using the 30-15 Intermittent Fitness Test (Buchheit formula), expressed in ml/kg/min.

Baseline, Week 3, and Week 6
Change in Positive Acceleration
Time Frame: Baseline, Week 3, and Week 6

Positive acceleration was recorded using the Polar Team Pro GPS system, expressed in meters per second squared (m/s²).

Baseline, Week 3, and Week 6
Change in Sprint Distance
Time Frame: Baseline, Week 3, and Week 6

Sprint distance was recorded using the Polar Team Pro GPS system, expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Distance Covered per Running Speed Zone
Time Frame: Baseline, Week 3, and Week 6

Distance covered was categorized into five speed zones using the Polar Team Pro GPS system: Zone 1 (0-6 km/h), Zone 2 (6.1-12 km/h), Zone 3 (12.1-15.4 km/h), Zone 4 (15.5-18.3 km/h), and Zone 5 (>18.4 km/h), expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Player Load
Time Frame: Baseline, Week 3, and Week 6

Player load, a composite measure of physical demand, was recorded using the Polar Team Pro GPS tracking system, expressed in arbitrary units (AU).

Baseline, Week 3, and Week 6
Change in Total Distance Covered
Time Frame: Baseline, Week 3, and Week 6

Total distance covered during small-sided games was recorded using the Polar Team Pro GPS system, expressed in meters (m).

Baseline, Week 3, and Week 6
Change in Technical Performance Parameters
Time Frame: Baseline, Week 3, and Week 6

Technical performance (accurate passes, inaccurate passes, dribbles, one-on-one battles, feints, and ball losses) was recorded via video analysis (GoPro Hero 12 Black) using computerized notational coding, expressed as count of actions.

Baseline, Week 3, and Week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2024

Primary Completion (Actual)

January 5, 2025

Study Completion (Actual)

April 28, 2025

Study Registration Dates

First Submitted

May 7, 2026

First Submitted That Met QC Criteria

September 24, 2026

First Posted (Actual)

September 28, 2026

Study Record Updates

Last Update Posted (Actual)

September 28, 2026

Last Update Submitted That Met QC Criteria

September 24, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-01-107

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe